Plus Therapeutics Highlights Three REYOBIQâ„¢ Clinical Data Presentations at 2025 WFNOS/SNO … | News
Cohort 1 data from multiple dose ReSPECT-Leptomeningeal Metastases (LM) trial showed no dosage limiting toxicity kAmk6>m#6$!tr%\v=:@3=2DE@>2 Wvq|X EC:2=…